These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 31313595)
41. 4-aminoquinazoline analogs: a novel class of anticancer agents. Singh K; Sharma PP; Kumar A; Chaudhary A; Roy RK Mini Rev Med Chem; 2013 Jun; 13(8):1177-94. PubMed ID: 22697512 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents. Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and Molecular Docking of Some Novel Thiazoles and Thiadiazoles Incorporating Pyranochromene Moiety as Potent Anticancer Agents. Gomha SM; Abdelhamid AO; Kandil OM; Kandeel SM; Abdelrehem NA Mini Rev Med Chem; 2018; 18(19):1670-1682. PubMed ID: 29692239 [TBL] [Abstract][Full Text] [Related]
44. Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents. El-Nassan HB Eur J Med Chem; 2013 Apr; 62():614-31. PubMed ID: 23434636 [TBL] [Abstract][Full Text] [Related]
45. Thiazole: A Review on Chemistry, Synthesis and Therapeutic Importance of its Derivatives. Chhabria MT; Patel S; Modi P; Brahmkshatriya PS Curr Top Med Chem; 2016; 16(26):2841-2862. PubMed ID: 27150376 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues. Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392 [TBL] [Abstract][Full Text] [Related]
49. 1,2,3-Triazole hybrids as anticancer agents: A review. Alam MM Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100158. PubMed ID: 34559414 [TBL] [Abstract][Full Text] [Related]
50. Cyclin dependent kinase (CDK) inhibitors as anticancer drugs. Sánchez-Martínez C; Gelbert LM; Lallena MJ; de Dios A Bioorg Med Chem Lett; 2015 Sep; 25(17):3420-35. PubMed ID: 26115571 [TBL] [Abstract][Full Text] [Related]
51. Synthesis, antitumor activity and mechanism of action of novel 1,3-thiazole derivatives containing hydrazide-hydrazone and carboxamide moiety. He H; Wang X; Shi L; Yin W; Yang Z; He H; Liang Y Bioorg Med Chem Lett; 2016 Jul; 26(14):3263-3270. PubMed ID: 27262600 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents. Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors. Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937 [TBL] [Abstract][Full Text] [Related]
55. Bioactive thiazole and benzothiazole derivatives. Rouf A; Tanyeli C Eur J Med Chem; 2015 Jun; 97():911-27. PubMed ID: 25455640 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and antitumor activity of α-aminophosphonates containing thiazole[5,4-b]pyridine moiety. Gu L; Jin C Org Biomol Chem; 2012 Sep; 10(35):7098-102. PubMed ID: 22850968 [TBL] [Abstract][Full Text] [Related]
57. Sulphur Containing Heterocyclic Compounds as Anticancer Agents. Kaur B; Singh G; Sharma V; Singh I Anticancer Agents Med Chem; 2023; 23(8):869-881. PubMed ID: 36545721 [TBL] [Abstract][Full Text] [Related]
58. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents. Kathiravan MK; Kale AN; Nilewar S Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098 [TBL] [Abstract][Full Text] [Related]
59. Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery. Liu H; Liu K; Dong Z Cancer Res; 2021 Jan; 81(1):18-26. PubMed ID: 32958547 [TBL] [Abstract][Full Text] [Related]
60. Involvement of PI3K/Akt pathway in prostate cancer--potential strategies for developing targeted therapies. Pommery N; Hénichart JP Mini Rev Med Chem; 2005 Dec; 5(12):1125-32. PubMed ID: 16375758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]